[ad_1]
After the United States and England, the European Union also appointed Turkish partner BNT162b2 Prof. Uğur Şahin and his wife Özlem Türeci approved the corona virus vaccine developed in Germany.
The approval will be valid for 27 countries. Speaking to the German newspaper Bild after approval, Prof. Uğur Şahin stated that everyone in German society should live by rules of mutual respect.
EQUAL OPPORTUNITIES SHOULD BE OFFERED TO MIGRANTS
Şahin said: “We have shown what can be done if everyone has the same opportunities. Immigrants or Germans, everyone should have the same opportunities. This also applies to newly arrived immigrants. People from 60 different countries work in our BioNTech. My parents used to get up at 04.30 in the morning to go to work to teach us and give a better education. Importance must be given to the education of children and young people so that it is beneficial to society ”.
Who will get vaccinated first?
Stating that they are currently working on vaccines or cancer drugs, Şahin said: “Who should get vaccinated first in Germany? Should we start with Prime Minister Merkel? “He said that each country has different rules and styles of vaccine management.
He recalled that the ethics committees will decide this, that there are celebrity campaigns in England, and that each country must make its own decision to explain the vaccine to the public more clearly.
“OUR WEALTH IS FOR RESEARCH”
When asked if BioNTech shares have skyrocketed and the company is highly valued, but will continue to bike, Şahin said;
“I keep doing that. Now there are measures and most of us work from home or from the office. I want to get back to normal as soon as possible and continue with the style that I am used to. The valuation of shares or the increase in the value of the company is not a situation that affects our lives. I consider this important to save people and make more investments in the health field. “
1.3 MILLION VACCINES AT THE END OF THE YEAR
The Bild newspaper, which lists Uğur Şahin as an example for other immigrants, also announced that Germany will buy 1.3 million BioNTech vaccines by the end of the year.
It was indicated that the first distribution of vaccines in Germany will begin on December 26 and the process will be carried out by the Paul-Ehrlich Institute and the first vaccination will take place on December 27.
[ad_2]